{"id":"cartilife","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"CartiLife appears to be a cartilage regeneration or restoration therapy in early clinical development. Given the name and phase 2 status, it likely involves cellular or biomaterial-based approaches to address cartilage defects or osteoarthritis. The exact mechanism—whether cell transplantation, scaffold-based regeneration, or growth factor delivery—is not publicly detailed.","oneSentence":"CartiLife is a regenerative medicine therapy designed to repair or regenerate cartilage tissue, likely through cell-based or tissue engineering approaches.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:49:34.201Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cartilage defects or osteoarthritis (presumed, based on product name)"}]},"trialDetails":[{"nctId":"NCT04744402","phase":"PHASE2","title":"Phase 2 Clinical Trial of CartiLife® in the United States","status":"UNKNOWN","sponsor":"Biosolution Co., Ltd.","startDate":"2020-10-28","conditions":"Articular Cartilage Defect, Articular Cartilage Degeneration","enrollment":25},{"nctId":"NCT05051332","phase":"PHASE3","title":"Phase 3 Clinical Trial of CartiLife® in Korea","status":"UNKNOWN","sponsor":"Biosolution Co., Ltd.","startDate":"2020-03-19","conditions":"Articular Cartilage Defect, Articular Cartilage Degeneration","enrollment":104},{"nctId":"NCT03545269","phase":"PHASE2","title":"Study to Assess the Efficacy and Safety of Treatment of Articular Cartilage Lesions With CartiLife®","status":"COMPLETED","sponsor":"Biosolution Co., Ltd.","startDate":"2014-02-03","conditions":"Articular Cartilage Lesion of the Knee","enrollment":30},{"nctId":"NCT03517046","phase":"PHASE1","title":"Study to Assess the Safety of Treatment of Articular Cartilage Lesions With CartiLife®","status":"COMPLETED","sponsor":"Biosolution Co., Ltd.","startDate":"2012-07-17","conditions":"Articular Cartilage Lesion of Knee","enrollment":6}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CartiLife","genericName":"CartiLife","companyName":"Biosolution Co., Ltd.","companyId":"biosolution-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CartiLife is a regenerative medicine therapy designed to repair or regenerate cartilage tissue, likely through cell-based or tissue engineering approaches. Used for Cartilage defects or osteoarthritis (presumed, based on product name).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}